iBio (IBIO) Accumulated Depreciation & Amortization (2016 - 2025)
iBio (IBIO) has disclosed Accumulated Depreciation & Amortization for 11 consecutive years, with $1.8 million as the latest value for Q4 2025.
- On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a N/A change, with the full-year FY2025 number at $1.5 million, up 47.87% from a year prior.
- Accumulated Depreciation & Amortization was $1.8 million for Q4 2025 at iBio, up from $1.6 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.8 million in Q1 2022 to a low of $115000.0 in Q4 2022.
- A 5-year average of $1.1 million and a median of $1.0 million in 2021 define the central range for Accumulated Depreciation & Amortization.
- Peak YoY movement for Accumulated Depreciation & Amortization: plummeted 91.48% in 2023, then skyrocketed 280.0% in 2024.
- iBio's Accumulated Depreciation & Amortization stood at $1.2 million in 2021, then crashed by 90.61% to $115000.0 in 2022, then surged by 391.3% to $565000.0 in 2023, then skyrocketed by 78.94% to $1.0 million in 2024, then soared by 73.99% to $1.8 million in 2025.
- Per Business Quant, the three most recent readings for IBIO's Accumulated Depreciation & Amortization are $1.8 million (Q4 2025), $1.6 million (Q3 2025), and $1.5 million (Q2 2025).